Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Apr 28;13(9):2132. doi: 10.3390/cancers13092132

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Overall survival (OS) (a) and progression-free survival (PFS) (b) at different time-points (1–6 years). Data points were obtained from the original papers in the text or derived from the graphs. The data points connected with full lines represent (mainly) synchronous, and with striped lines (mainly) metachronous oligometastatic disease. For comparison, in Figure 2a, the 1y and 2y OS results are shown from the Keynote-024 RCT (KN024) on metastatic disease treated with chemo (blue diamonds) or ICI (red diamonds), without LAT. Bauml: PFS-L is reported. Only ‘Bauml’ and ‘KN024 pembro’ show patients with ICI treatment.